Skip to main content
editorial
. 2020 May 27;5(2):1–53. doi: 10.1159/000508300

Fig. 18.

Fig. 18

Pharmaceutical Committee programme for the next 5 years, 2019. CAPs, centrally authorized products; EMA, European Medicines Agency; ATMPs, advanced therapy medicinal products; APIs, active pharmaceutical ingredients; AI, artificial intelligence; AMR, antimicrobial resistance. Source: Pharmaceutical Committee [158].